Literature DB >> 30723384

Improved error detection using a divided treatment plan in volume modulated arc therapy.

Kazuo Tarutani1,2, Masao Tanooka1,3, Hiroshi Doi1,4, Masayuki Fujiwara1, Masaki Miyashita2, Kazufumi Kagawa2, Norihiko Kamikonya2, Koichiro Yamakado1.   

Abstract

AIM: We sought to improve error detection ability during volume modulated arc therapy (VMAT) by dividing and evaluating the treatment plan.
BACKGROUND: VMAT involves moving a beam source delivering radiation to tumor tissue through an arc, which significantly decreases treatment time. Treatment planning for VMAT involves many parameters. Quality assurance before treatment is a major focus of research.
MATERIALS AND METHODS: We used an established VMAT prostate treatment plan and divided it into 12° × 30° sections. In all the sections, only image data that generated errors in one segment and those that were integrally acquired were evaluated by a gamma analysis. This was done with five different patient plans.
RESULTS: The integrated image data resulting from errors in each section was 100% (tolerance 0.5 mm/0.5%) in the gamma analysis result in all image data. Division of the treatment plans produced a shift in the mean value of each gamma analysis in the cranial, left, and ventral directions of 94.59%, 98.83%, 96.58%, and the discrimination ability improved.
CONCLUSION: The error discrimination ability was improved by dividing and verifying the portal imaging.

Entities:  

Keywords:  Electronic portal imaging device; Setup error; Volume modulated arc therapy

Year:  2019        PMID: 30723384      PMCID: PMC6352744          DOI: 10.1016/j.rpor.2018.12.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  27 in total

1.  Evaluation of the gamma dose distribution comparison method.

Authors:  Daniel A Low; James F Dempsey
Journal:  Med Phys       Date:  2003-09       Impact factor: 4.071

2.  Dosimetric IMRT verification with a flat-panel EPID.

Authors:  B Warkentin; S Steciw; S Rathee; B G Fallone
Journal:  Med Phys       Date:  2003-12       Impact factor: 4.071

Review 3.  Facilitation of radiotherapeutic error by computerized record and verify systems.

Authors:  Gregory A Patton; David K Gaffney; John H Moeller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

4.  Pretreatment verification of IMRT absolute dose distributions using a commercial a-Si EPID.

Authors:  C Talamonti; M Casati; M Bucciolini
Journal:  Med Phys       Date:  2006-11       Impact factor: 4.071

5.  Volumetric modulated arc therapy: IMRT in a single gantry arc.

Authors:  Karl Otto
Journal:  Med Phys       Date:  2008-01       Impact factor: 4.071

6.  Error in the delivery of radiation therapy: results of a quality assurance review.

Authors:  Grace Huang; Gaylene Medlam; Justin Lee; Susan Billingsley; Jean-Pierre Bissonnette; Jolie Ringash; Gabrielle Kane; David C Hodgson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

7.  3D Dosimetric verification of volumetric-modulated arc therapy by portal dosimetry.

Authors:  Anton Mans; Peter Remeijer; Igor Olaciregui-Ruiz; Markus Wendling; Jan-Jakob Sonke; Ben Mijnheer; Marcel van Herk; Joep C Stroom
Journal:  Radiother Oncol       Date:  2010-01-19       Impact factor: 6.280

8.  Reduction of prostate motion by removal of gas in rectum during radiotherapy.

Authors:  Ichiro Ogino; Hiroji Uemura; Tomio Inoue; Yoshinobu Kubota; Kazuto Nomura; Naoyuki Okamoto
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

9.  A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments.

Authors:  Markus Wendling; Leah N McDermott; Anton Mans; Jan-Jakob Sonke; Marcel van Herk; Ben J Mijnheer
Journal:  Med Phys       Date:  2009-07       Impact factor: 4.071

10.  In vivo dosimetry for prostate cancer patients using an electronic portal imaging device (EPID); demonstration of internal organ motion.

Authors:  M Kroonwijk; K L Pasma; S Quint; P C Koper; A G Visser; B J Heijmen
Journal:  Radiother Oncol       Date:  1998-11       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.